Literature DB >> 12541746

[Determination of bromhexine in plasma by gas chromatography-electron capture detection and pharmacokinetic studies].

L L Yang1, Y S Yuan, X D Tu.   

Abstract

This paper reports a gas chromatography-electron capture detection(GC-ECD) method for the study of pharmacokinetics of bromhexine in healthy human body. A2 m x 3 mm i.d. silanized glass column packed with 5% SE-30 was used. The carrier gas was nitrogen. The internal standard was 5-chloro-2-amino-diphenyl ketone. After NaH2PO4-Na2HPO4 buffer (pH 6.0) being added, the plasma was extracted with n-hexane-dichloromethane (9:1, V/V). A good linearity was obtained from 1.0 microgram/L to 50.0 micrograms/L of bromhexine in human plasma, r = 0.9994. The detection limit of bromhexine in plasma was 0.5 microgram/L. The average recovery was 97.5%. The pharmacokinetics of bromhexine was determined by this method after a single oral dose of 8 mg bromhexine capsule given to each of 8 volunteers. The results showed that the plasma concentration-time courses conformed to one compartment model. The established GC-ECD method is a good method for the determination of bromhexine in human plasma. The method is rapid, simple, precise and sensitive.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12541746

Source DB:  PubMed          Journal:  Se Pu        ISSN: 1000-8713


  3 in total

Review 1.  Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment.

Authors:  Zemene Demelash Kifle; Akeberegn Gorems Ayele; Engidaw Fentahun Enyew
Journal:  J Environ Public Health       Date:  2021-04-22

2.  Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study.

Authors:  Ting Li; Laifang Sun; Wenwu Zhang; Chanfan Zheng; Chenchen Jiang; Mingjing Chen; Di Chen; Zhijuan Dai; Shihui Bao; Xian Shen
Journal:  Clin Transl Sci       Date:  2020-10-10       Impact factor: 4.689

3.  Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19.

Authors:  Qibo Fu; Xiao Zheng; Yunlian Zhou; Lanfang Tang; Zhimin Chen; Shaoqing Ni
Journal:  Eur J Clin Pharmacol       Date:  2020-09-01       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.